This article first appeared on GuruFocus .
Release Date: July 30, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Niva Bupa Health Insurance Co Ltd ( NSE:NIVABUPA ) reported strong growth, with overall like-to-like growth of 23% and retail health growth of 35.5%, outpacing the industry.
-
Profit after tax improved to Rs 137.8 crores in Q1, with the combined insurance service ratio improving by 300 basis points to 100.2%.
-
The company's retail loss ratio improved by 90 basis points to 67.5%, driven by better underwriting and a focus on profitable segments.
-
Niva Bupa Health Insurance Co Ltd ( NSE:NIVABUPA ) achieved a top 50 ranking in 'Great Places to Work' and improved its NPS score to 62, reflecting strong customer and employee satisfaction.
-
The company's preferred provider network (PPN) strategy is yielding results, with 22% of claims closing in PPN hospitals, leading to 15-30% lower average claim sizes for like-to-like treatments.
-
The company maintains a healthy solvency ratio of 2.25, well above the regulatory minimum, and has an AAA issuer rating from ICRA.
Negative Points
-
Niva Bupa Health Insurance Co Ltd ( NSE:NIVABUPA ) experienced flat growth in the group business due to a challenging pricing environment, with the company choosing not to write large group accounts that do not meet underwriting philosophy.
-
The expense ratio increased by 90 basis points due to a mix change towards retail health, although this was offset by a reduction in loss ratio.
-
The company faces headwinds from the GST impact, which will continue to affect expense ratios until Q3, when results become comparable year-over-year.
-
The back book loss ratio remains elevated at around 75%, requiring annual price increases of high single digits to manage profitability.
-
The company's investment yield is relatively modest at 7.2%, and while it is increasing allocations to AIFs and ETFs, it remains conservative in its investment strategy.
-
The company's growth is partly dependent on sustaining a 8-10% growth premium over the market, which may be challenging given the competitive landscape and elevated base in the second half.
Q & A Highlights
-
Warning! GuruFocus has detected 4 Warning Sign with NSE:NIVABUPA.
-
Is NSE:NIVABUPA fairly valued? Test your thesis with our free DCF calculator.
Q: What has been the trend in the loss ratio for July, and what is the outlook for the rest of the year? Additionally, can you explain the sharp increase in the net reinsurance expense line item? A: Vishwanath Mahendra (CFO) stated that the July loss ratio trend is in line with expectations, with no unusual trends observed. The Q1 YoY improvement is driven by better retail new business performance and a strategic decision to avoid large group accounts that don't meet underwriting philosophy. Regarding the reinsurance expense, he clarified there is nothing structurally different; the line item includes items like profit commissions that can be booked in different quarters, and it should converge with historical trends as the year progresses.
Q: Is there any change in internal strategy to sustain a higher growth rate compared to the industry, and what is the expected retail and group health mix going forward? A: Krishnan Ramachandran (MD & CEO) confirmed the strategy remains consistent, focusing on a diversified multi-channel mix and the "Bharat initiative" to penetrate tier 2 and tier 3 towns. The company expects to sustain growth 8-10 percentage points faster than the market in retail health. Ankur Kharwanda (Executive Director & Deputy CEO) added that they are expanding the advisor network and launching new products like Reatio 3.0. The internal target for the business mix remains around 70% retail and 30% group.
Q: What is the growth breakdown between fresh and renewal business in retail, and how does the Preferred Provider Network (PPN) strategy impact the loss ratio? A: Ankur Kharwanda (Executive Director & Deputy CEO) noted that retail business grew 46.5% in Q1, with renewals growing 41%, indicating strong performance in both segments. Dr. Bhabatosh Mishra (COO) explained that the PPN strategy guides customers to secondary care-plus hospitals, which can result in a 15-20 percentage point lower average claim size for like-to-like treatments compared to tertiary or quaternary care setups. This, along with better working relationships to avoid unnecessary ICU admissions or prolonged stays, helps reduce claim costs.
Q: How have loss ratios played out between the fresh book and the older back book, and what is the trajectory for the back book? A: Vishwanath Mahendra (CFO) stated that the back book loss ratio is broadly around 75%. He attributed the overall improvement in the combined ratio to pricing actions, the PPN strategy, and a favorable business mix shift between retail and group. The company manages the back book through annual price increases in the high single digits.
Q: With the GST base effect normalizing in the second half, will the loss ratio deteriorate, and how should we think about the combined ratio? A: Vishwanath Mahendra (CFO) explained that since the results are based on earned premium amortized over time, there shouldn't be a material change in the loss ratio between H1 and H2. Any minor impact would be offset by a reduction in expenses. He reiterated that on a like-to-like basis, there is no inherent reason for the combined ratio to deteriorate, barring any abnormal infection season.
Q: Why is the company raising up to Rs 500 crore in debt, and what is the strategy for the investment book? A: Vishwanath Mahendra (CFO) explained that the company has a Rs 250 crore NCD with a call option due this financial year, which was raised at a higher coupon of 10.7% five years ago. Given the company's AAA issuer rating and growth plans, they have an enabling resolution to raise funds at better rates. Vikas Jain (CIO) added that the investment strategy remains conservative, with increased allocation to Nifty ETFs (around 3.5% of the book) and investments in performing credit AIFs, which yield between 12-15%, with the potential to reach the regulatory limit of 5% of AUM.
Q: Can you explain the divergence between the 29% growth in insurance service revenue and the 23% growth in GWP? A: Vishwanath Mahendra (CFO) clarified that insurance service revenue is on an earnings basis, amortized over the policy period (1/365 basis). Therefore, it reflects the amortization of policies written in the current and previous years, including multi-year policies, and will not exactly match the GWP growth in a single quarter.
Q: What is the target for the expense ratio and ROE trajectory for FY27 and FY28? A: Vishwanath Mahendra (CFO) stated that the expense of management ratio has improved to 35.2% from 38% last year and is expected to stabilize in the 32-33% range. On ROE, the company maintains its FY29 guidance of mid-to-high teens. The current rolling four-quarter ROE is 11.8%, and the trajectory is expected to be smooth, reaching the target by FY29.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
